Early Protein Supplementation on Prevention of Hyperkalemia
This study has been completed.
Sponsor:
The University of Texas Health Science Center at San Antonio
Information provided by (Responsible Party):
Cynthia Blanco, The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier:
NCT00290160
First received: February 8, 2006
Last updated: December 6, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Evaluate if early protein supplementation decreases the incidence of hyperkalemia in Extremely Low Birth Weight Infants (babies less than 1,000 grams birth weight).
| Condition | Intervention |
|---|---|
|
Hyperkalemia |
Behavioral: Protein supplementation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Double-Blind Primary Purpose: Prevention |
| Official Title: | The Effect of Early Protein Supplementation on Prevention of Hyperkalemia in Extremely Low Birth Weight Infants |
Resource links provided by NLM:
Further study details as provided by The University of Texas Health Science Center at San Antonio:
Primary Outcome Measures:
- Incidence of hyperkalemia in between groups
Secondary Outcome Measures:
- Incidence of hyperglycemia, post-natal growth, neurodevelopmental outcome at 18 months
| Estimated Enrollment: | 62 |
| Study Start Date: | December 2002 |
| Study Completion Date: | July 2007 |
| Primary Completion Date: | September 2005 (Final data collection date for primary outcome measure) |
Show Detailed Description
Eligibility| Ages Eligible for Study: | up to 12 Hours |
| Genders Eligible for Study: | Both |
Criteria
Inclusion Criteria: ELBW infants with birth weight <1000 grams . Enrollment within the first 12 hr of life.
Exclusion Criteria: major congenital anomalies; gestational age less than 24 weeks, infants not resuscitated, death.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00290160
Locations
| United States, Texas | |
| University Health System | |
| San Antonio, Texas, United States, 78229 | |
Sponsors and Collaborators
The University of Texas Health Science Center at San Antonio
Investigators
| Principal Investigator: | Cynthia L Blanco, MD | University of Texas |
More Information
No publications provided by The University of Texas Health Science Center at San Antonio
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Cynthia Blanco, Associate Professor, The University of Texas Health Science Center at San Antonio |
| ClinicalTrials.gov Identifier: | NCT00290160 History of Changes |
| Other Study ID Numbers: | 012-9000-400 |
| Study First Received: | February 8, 2006 |
| Last Updated: | December 6, 2012 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by The University of Texas Health Science Center at San Antonio:
|
Hyperkalemia Protein Hyperglycemia ELBW |
Additional relevant MeSH terms:
|
Hyperkalemia Water-Electrolyte Imbalance Metabolic Diseases |
ClinicalTrials.gov processed this record on May 22, 2013